Home » Topics » Regulatory » Patents

Patents
RSS

Novel histamine H3 receptor antagonists/inverse agonists disclosed

Dec. 16, 2011

New conjugated antisense oligonucleotides prepared in U.S.

Dec. 16, 2011

Novel protein kinase inhibitors reported

Dec. 16, 2011

OSI Pharmaceuticals presents new macrophage-stimulating protein receptor inhibitors

Dec. 15, 2011

Novel antibacterial and antifungal agents disclosed by A*STAR

Dec. 15, 2011

New histamine H3 receptor modulators presented

Dec. 15, 2011

Researchers at Chemilia design new anticancer agents

Dec. 15, 2011

New serine/threonine-protein kinase ATR inhibitors claimed

Dec. 15, 2011

Novel histamine H3 receptor antagonists/inverse agonists reported

Dec. 14, 2011

New inhibitors of cytokine signaling designed in U.S.

Dec. 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...